Poisoning with anti-hypertensive drugs: alpha-adrenoceptor antagonists.
Lip GY, Ferner RE.
J Hum Hypertens. 1995 Jul;9(7):523-6.
Tonic inhibition of allergic itch signaling by the descending noradrenergic system in mice.
Gotoh Y, Omori Y, Andoh T, Kuraishi Y.
J Pharmacol Sci. 2011;115(3):417-20. doi: 10.1254/jphs.10305sc. Epub 2011 Mar 2.
Tetrodotoxin-dependent effects of menthol on mouse gastric motor function.
Amato A, Baldassano S, Serio R, Mulè F.
Eur J Pharmacol. 2013 Oct 15;718(1-3):131-7. doi: 10.1016/j.ejphar.2013.08.042. Epub 2013 Sep 13.
Naphazoline intoxication managed with minimally invasive cardiac output monitoring.
Oishi T, Kashiura M, Yasuda H, Kishihara Y, Tominaga K, Tamura H, Moriya T.
Am J Emerg Med. 2024 Mar;77:233.e5-233.e7. doi: 10.1016/j.ajem.2023.12.034. Epub 2023 Dec 24.
Dopamine DA2-receptor activation inhibits noradrenaline release in human kidney slices.
Rump LC, Schwertfeger E, Schuster MJ, Schaible U, Frankenschmidt A, Schollmeyer PJ.
Kidney Int. 1993 Jan;43(1):197-204. doi: 10.1038/ki.1993.32.
Investigation into the contractile response of melatonin in the guinea-pig isolated proximal colon: the role of 5-HT4 and melatonin receptors.
Lucchelli A, Santagostino-Barbone MG, Tonini M.
Br J Pharmacol. 1997 Aug;121(8):1775-81. doi: 10.1038/sj.bjp.0701287.
Nicotinic acetylcholine receptor blocking effect of guanethidine in the rat gastric fundus.
Blommaart PJ, Ferwerda G, Kodde A, Tytgat GN, Boeckxstaens GE.
Br J Pharmacol. 1999 Oct;128(4):903-8. doi: 10.1038/sj.bjp.0702865.
Characterization of receptors mediating the effects of dopamine on gastric smooth muscle.
Kurosawa S, Hasler WL, Torres G, Wiley JW, Owyang C.
Gastroenterology. 1991 May;100(5 Pt 1):1224-31.
Contribution of alpha-adrenoceptors to depolarization and contraction evoked by continuous asynchronous sympathetic nerve activity in rat tail artery.
Brock JA, McLachlan EM, Rayner SE.
Br J Pharmacol. 1997 Apr;120(8):1513-21. doi: 10.1038/sj.bjp.0701055.
Release of [3H]-noradrenaline from the sympathetic nerves to bovine mesenteric lymphatic vessels and its modification by alpha-agonists and antagonists.
Allen JM, McCarron JG, McHale NG, Thornbury KD.
Br J Pharmacol. 1988 Jul;94(3):823-33. doi: 10.1111/j.1476-5381.1988.tb11593.x.
